This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Actinic Keratosis
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of the study is to demonstrate that ingenol mebutate gel is efficacious in treating Actinic Keratoses (AKs) present 8 weeks after initial field treatment or emerging in a previously cleared field.

Provided treatments

  • Drug: Ingenol mebutate gel, 0.015%
  • Drug: Vehicle gel
Tris trial is registered with FDA with number: NCT01600014. The sponsor of the trial is LEO Pharma and it is looking for 463 volunteers for the current phase.
Official trial title:
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp